Hemostasis Valve Market Size, Share & Growth Report 2032

Hemostasis Valves Market: Industry Perspective

The global hemostasis valves market size was worth around USD 169.4 million in 2023 and is predicted to grow to around USD 257 million by 2032 with a compound annual growth rate (CAGR) of roughly 4.86% between 2024 and 2032.

Request Free Sample

Introduction

A Hemostasis valve is regularly utilized in neuroendovascular surgeries to reduce the thromboembolism risk. Moreover, new kinds of hemostasis valves referred to as guardian hemostasis valves were introduced in the first decade of the twenty-first century to minimize blood loss in patients.

Additionally, hemostasis valves help healthcare providers in raising the proficiency of next-generation catheters as well as delivery systems. Investors in the hemostasis valves industry are investing massively in research activities for creating new medical devices with innovative designs that can fulfill consumer requirements & necessities.

Request Free Sample

Market Growth Dynamics

The surge in the number of interventional surgical methods, a prominent rise in hospitals & clinics, and a rise in the aging population prone to heart or cardiac disorders are likely to drive the growth of the hemostasis valve over the forecast period. Moreover, hemostasis valves are used on a large scale in interventional surgical procedures like percutaneous transluminal coronary angioplasty for reducing the loss of blood after interventional instrument insertion in human vasculature.  A prominent bulge in incidences of heart disorders has resulted in a steep increase in endovascular surgeries, thereby driving the market trends.  

Furthermore, the introduction of new products by the market players and strategic business strategies like product innovation are likely to steer the growth of the market over the forthcoming years. An inactive lifestyle and a rise in the cases of obesity across the globe are expected to chart a profitable roadmap for hemostasis valves over the years to come.

Hemostasis Valves Market: Report Scope

Regional Analysis:

• North America To Account For Major Market Share By 2032

The regional market growth over the forecast period is attributed to massive inflation in the geriatric population, an increase in the number of coronary artery ailments, and a rise in the proportion of interventional surgeries in countries like the U.S. and Canada.  Moreover, the huge presence of giant players in countries like the U.S. will further prompt business growth over the forthcoming years. The availability of advanced healthcare infrastructure facilities and high disposable incomes are likely to define the growth of the hemostasis valve industry in the North American sub-continent.

Hemostasis Valves Market: Competitive Analysis

The global hemostasis valves market is dominated by players like:

• Minivalve
• Merit Medical
• GaltNeedleTech
• Ambu
• St. Jude Medical
• Teleflex
• B. Braun
• Qosina
• Excel Medical Products
• Abbott
• Armstrong Medical
• Ceodeux Meditec

The global Hemostasis Valve Market is segmented as follows:

By Type Segment Analysis

• Hemostasis Valve Y-connectors
• Double Y-connector Hemostasis Valves
• One-handed Hemostasis Valves
• Other Hemostasis Valves

By Application Segment Analysis

• Angiography
• Angioplasty

By End-User Segment Analysis

• Hospitals
• Other End Users

By Regional Segment Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa